Capillary leak syndrome pathophysiology: Difference between revisions
No edit summary |
(added overview) |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The pathogenesis of capillary leak syndrome remain unclear, however, '''[[cytokines]]''', '''[[vascular endothelial growth factor]]''' (VEGF), '''[[leukotrienes]]''', and '''complement''' play an important role. During each episode of hyperpermeability of the vasculature, there is an increase of interleukin 2 receptor-positive peripheral blood M-cell count, as well as apoptosis of endothelial cells. | |||
==Pathophysiology== | ==Pathophysiology== | ||
Capillary leak syndrome also known as '''''Clarkson's disease''''' and '''''spontaneous periodic edema''''' is a life threatening condition characterized by recurrent episodes of hypovolemic shock, hemoconcentration, and hypoalbuminemia, occurring in the absence of albuminuria. | Capillary leak syndrome also known as '''''Clarkson's disease''''' and '''''spontaneous periodic edema''''' is a life threatening condition characterized by recurrent episodes of [[hypovolemic shock]], [[hemoconcentration]], and [[hypoalbuminemia]], occurring in the absence of [[albuminuria]]. | ||
The pathogenesis of capillary leak syndrome remain unclear, however, '''cytokines''', '''vascular endothelial growth factor''' (VEGF), '''leukotrienes''', and '''complement''' play an important role. During each episode of hyperpermeability of the vasculature, there is an increase of interleukin 2 receptor-positive peripheral blood M-cell count. The exact cause of hyperpermeability remains unknown, and protein up to 900 kDa can extravasate from the vasculature. During the hyperpermeability episode, endothelial cells undergo apoptosis, which is characterized by endothelial microvascular body and bleb formation. <ref name="pmid20634497">{{cite journal| author=Kapoor P, Greipp PT, Schaefer EW, Mandrekar SJ, Kamal AH, Gonzalez-Paz NC | display-authors=etal| title=Idiopathic systemic capillary leak syndrome (Clarkson's disease): the Mayo clinic experience. | journal=Mayo Clin Proc | year= 2010 | volume= 85 | issue= 10 | pages= 905-12 | pmid=20634497 | doi=10.4065/mcp.2010.0159 | pmc=2947962 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20634497 }} </ref> | The pathogenesis of capillary leak syndrome remain unclear, however, '''[[cytokines]]''', '''[[vascular endothelial growth factor]]''' (VEGF), '''[[leukotrienes]]''', and '''complement''' play an important role. During each episode of hyperpermeability of the vasculature, there is an increase of interleukin 2 receptor-positive peripheral blood M-cell count. The exact cause of hyperpermeability remains unknown, and protein up to 900 kDa can extravasate from the vasculature. During the hyperpermeability episode, endothelial cells undergo [[apoptosis]], which is characterized by endothelial microvascular body and bleb formation. <ref name="pmid20634497">{{cite journal| author=Kapoor P, Greipp PT, Schaefer EW, Mandrekar SJ, Kamal AH, Gonzalez-Paz NC | display-authors=etal| title=Idiopathic systemic capillary leak syndrome (Clarkson's disease): the Mayo clinic experience. | journal=Mayo Clin Proc | year= 2010 | volume= 85 | issue= 10 | pages= 905-12 | pmid=20634497 | doi=10.4065/mcp.2010.0159 | pmc=2947962 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20634497 }} </ref> | ||
==References== | ==References== | ||
Revision as of 00:12, 7 August 2022
|
Capillary leak syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Capillary leak syndrome pathophysiology On the Web |
|
American Roentgen Ray Society Images of Capillary leak syndrome pathophysiology |
|
Risk calculators and risk factors for Capillary leak syndrome pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: M. Hassan, M.B.B.S
Overview
The pathogenesis of capillary leak syndrome remain unclear, however, cytokines, vascular endothelial growth factor (VEGF), leukotrienes, and complement play an important role. During each episode of hyperpermeability of the vasculature, there is an increase of interleukin 2 receptor-positive peripheral blood M-cell count, as well as apoptosis of endothelial cells.
Pathophysiology
Capillary leak syndrome also known as Clarkson's disease and spontaneous periodic edema is a life threatening condition characterized by recurrent episodes of hypovolemic shock, hemoconcentration, and hypoalbuminemia, occurring in the absence of albuminuria.
The pathogenesis of capillary leak syndrome remain unclear, however, cytokines, vascular endothelial growth factor (VEGF), leukotrienes, and complement play an important role. During each episode of hyperpermeability of the vasculature, there is an increase of interleukin 2 receptor-positive peripheral blood M-cell count. The exact cause of hyperpermeability remains unknown, and protein up to 900 kDa can extravasate from the vasculature. During the hyperpermeability episode, endothelial cells undergo apoptosis, which is characterized by endothelial microvascular body and bleb formation. [1]
References
- ↑ Kapoor P, Greipp PT, Schaefer EW, Mandrekar SJ, Kamal AH, Gonzalez-Paz NC; et al. (2010). "Idiopathic systemic capillary leak syndrome (Clarkson's disease): the Mayo clinic experience". Mayo Clin Proc. 85 (10): 905–12. doi:10.4065/mcp.2010.0159. PMC 2947962. PMID 20634497.